Shares of Moderna Inc. MRNA, +3.71% slipped 6.13% to $130.08 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP, +2.14% falling 0.74% to 11,544.91 and Dow Jones Industrial Average DJIA, +1.40% falling 0.55% to 31,145.30. This was the stock’s second consecutive day of losses. Moderna Inc. closed $334.77 short of its 52-week high ($464.85), which the company reached on September 10th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. ABBV, +0.81% rose 0.96% to $137.59, Amgen Inc. AMGN, +1.06% fell 0.06% to $242.22, and AstraZeneca PLC ADR AZN, -0.98% fell 0.46% to $60.41. Trading volume (5.8 M) eclipsed its 50-day average volume of 4.7 M.